33
/es/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
August 1, 2025
10193602
975418
2

8 mar 2024 año - Wegovy Approved by The FDA

Descripción:

The FDA expands the approval of semaglutide (Wegovy) to include heart disease, making it the first weight-loss drug to be approved for reducing the risk of cardiovascular events in adults who have cardiovascular disease and are either obese or overweight.

Añadido al timeline:

fecha:

8 mar 2024 año
Ahora mismo
~ 1 years and 3 months ago